Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.06.23 | Ascendis Pharma: One-Year Data from Phase 3 Trial of TransCon PTH in Adults with Hypoparathyroidism Presented at ENDO 2023 | 418 | GlobeNewswire (Europe) | - Oral presentation of results showed sustained improvements through Week 52, as well as safety and tolerability similar to that previously reported for the initial 26-week blinded portion of the... ► Artikel lesen | |
17.06.23 | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023 | 294 | GlobeNewswire (Europe) | -- Mean BMI reduction of 21.0% from baseline observed in 13 patients at six months, showing progression from 16.8% mean BMI reduction at 16 weeks -- -- Phase 3 trial evaluating setmelanotide in acquired... ► Artikel lesen | |
17.06.23 | Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress | 378 | GlobeNewswire (Europe) | New data at week 36 shows atacicept 150 mg resulted in a delta of 43% versus placebo in mean proteinuria reduction in per-protocol analysis and demonstrated statistically significant stabilization... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.476 |
TUI | 2.255 |
BAYER | 2.059 |
BYD | 1.993 |
NVIDIA | 1.688 |
COMMERZBANK | 1.648 |
MUTARES | 1.533 |
VOLKSWAGEN | 1.404 |
BASF | 1.310 |
MERCEDES-BENZ | 1.176 |
SUPER MICRO COMPUTER | 985 |
THYSSENKRUPP | 925 |
INTEL | 789 |
PLUG POWER | 732 |
ALIBABA | 729 |
NEL | 719 |
DEUTSCHE BANK | 644 |
TESLA | 621 |
DEUTSCHE LUFTHANSA | 612 |
AIXTRON SE | 601 |
JINKOSOLAR | 585 |
BIONTECH | 583 |
BP | 579 |
NOVO NORDISK | 555 |
PAYPAL | 525 |